Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to

Olivia A Skrobot1, Johannes Attems2, Margaret Esiri3

  • 1Dementia Research Group, School of Clinical Sciences, Faculty of Health Sciences, University of Bristol, Learning and Research Level 1, Southmead Hospital, Bristol, BS10 5NB, UK.

Insights

New guidelines (VCING) provide a standardized approach for assessing cerebrovascular disease in post-mortem brains, improving the diagnosis of vascular cognitive impairment. These reproducible criteria help neuropathologists predict the likelihood of cognitive impairment contribution from vascular factors.

Area of Science:

  • Neuropathology
  • Neuroscience
  • Vascular Dementia Research

Background:

  • Standardized post-mortem assessment protocols for vascular cognitive impairment (VCI) are lacking.
  • Cerebrovascular disease is a significant contributor to cognitive decline, necessitating reliable diagnostic methods.

Purpose of the Study:

  • To develop and validate a consensus-based neuropathology guideline (VCING) for assessing cerebrovascular disease in relation to VCI.
  • To establish reproducible criteria for post-mortem scoring of various pathologies and determine their predictive value for cognitive impairment.

Main Methods:

  • A Delphi method survey was used to agree on sampling protocols and scoring criteria among UK neuropathologists.
  • Inter-rater reliability was assessed using Gwet's AC2 coefficient.
  • The VCING criteria were validated through blinded post-mortem assessment of 113 individuals with prior cognitive evaluations.

Main Results:

  • High inter-rater agreement (AC2 > 0.8) was achieved for most assessed pathologies, including cerebral amyloid angiopathy, infarcts, and microhaemorrhages.
  • Arteriolosclerosis and microinfarct severity showed moderate agreement (0.45-0.84).
  • Seven key pathologies (leptomeningeal cerebral amyloid angiopathy, large/lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation, myelin loss) significantly predicted cognitive impairment.

Conclusions:

  • The developed Vascular Cognitive Impairment Neuropathology Guidelines (VCING) are reproducible and clinically predictive.
  • A preferred predictive model incorporating occipital leptomeningeal cerebral amyloid angiopathy, occipital white matter arteriolosclerosis, and large infarcts achieved 77% accuracy.
  • VCING criteria will aid neuropathologists in reporting the likelihood of cerebrovascular disease contributing to cognitive impairment.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
584
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
658
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
697